- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Bipolar Disorder Associated with High Risk of PCOS: Study
A recent study led by Jieyu Liu discovered a significant association between bipolar disorder (BD) and polycystic ovary syndrome (PCOS), unraveling the complex interplay between mental health and endocrine disturbances. The findings were published in the Journal of Affective Disorders.
With 72 drug-naïve BD patients, 98 healthy controls, and 72 BD patients on long-term medication, this study revealed that drug-naïve BD individuals exhibited a threefold higher prevalence of PCOS compared to their healthy counterparts, even after accounting for demographic factors (Odds Ratio: 3.02, 95% CI: 1.09–8.36).
The research delved into the impact of specific medications on PCOS within the BD population. Long-term treatment with valproate, a commonly prescribed mood stabilizer, was found to be a significant factor correlated with the increased occurrence and development of PCOS in BD patients (Odds Ratio: 3.89, 95% CI: 1.13–13.37).
The study also identified age and the insulin resistance index as additional factors influencing the prevalence of PCOS in BD patients, emphasizing the multifaceted nature of this association.
The findings underscore the importance of closely monitoring reproductive health, especially the incidence of PCOS, in individuals diagnosed with BD, particularly those prescribed valproate. The potential link between valproate use and PCOS raises critical questions about the long-term effects of commonly prescribed medications and necessitates a nuanced approach in the treatment of bipolar disorder.
This study also sparks discussions among healthcare professionals and researchers highlighting the need for comprehensive care for individuals with BD. Further investigations and heightened awareness are imperative to develop tailored treatment strategies and ensure the overall well-being of those managing both bipolar disorder and its associated health complications.
Reference:
Liu, J., Teng, Z., Xie, H., Yuan, H., Liu, M., Chen, J., Tang, H., Xiang, H., Wu, H., & Huang, J. (2023). Prevalence and characteristics of polycystic ovarian syndrome in patients with bipolar disorder. In Journal of Affective Disorders (Vol. 340, pp. 387–395). Elsevier BV. https://doi.org/10.1016/j.jad.2023.08.007
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751